The Metastatic Cascade as the Basis for Liquid Biopsy Development - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Frontiers in Oncology Année : 2020

The Metastatic Cascade as the Basis for Liquid Biopsy Development


The metastatic cascade describes the process whereby aggressive cancer cells leave the primary tumor, travel through the bloodstream, and eventually reach distant organs to develop one or several metastases. During the last decade, innovative technologies have exploited the recent biological knowledge to identify new circulating biomarkers for the screening and early detection of cancer, real-time monitoring of treatment response, assessment of tumor relapse risk (prognosis), identification of new therapeutic targets and resistance mechanisms, patient stratification, and therapeutic decision-making. These techniques are broadly described using the term of Liquid Biopsy. This field is in constant progression and is based on the detection of circulating tumor cells, circulating free nucleic acids (e.g., circulating tumor DNA), circulating tumor-derived extracellular vesicles, and tumor-educated platelets. The aim of this review is to describe the biological principles underlying the liquid biopsy concept and to discuss how functional studies can expand the clinical applications of these circulating biomarkers.
Fichier principal
Vignette du fichier
fonc-10-01055.pdf (1.55 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03257841 , version 1 (11-06-2021)




Zahra Eslami-S, Luis Enrique Cortés-Hernández, Catherine Alix-Panabières. The Metastatic Cascade as the Basis for Liquid Biopsy Development. Frontiers in Oncology, 2020, 10, pp.1055. ⟨10.3389/fonc.2020.01055⟩. ⟨hal-03257841⟩
12 Consultations
104 Téléchargements



Gmail Mastodon Facebook X LinkedIn More